FDA analytical procedures guidance
Analytical Procedures and Methods Validation for Drugs and Biologics
Current edition
July 2015
Current edition
July 2015
About this standard
Describes what analytical procedure and method validation information to submit in NDAs, ANDAs and BLAs, including validation characteristics, compendial procedures, reference standards and method transfer.
Recognition by market
Whether the market recognizes, harmonizes or adopts this standard, and which edition it accepts
No market listing is published yet.
Testing requirements that cite it
Open the market page and its pathway pages for the full requirement, protocol and report content
United States
- Analytical procedures: validation, compendial verification and method transferAnalytical method validation · Not stated
Related standards: Q2(R2), USP <1224>, USP <1225>, USP <1226>, USP <621>, Q14, M10, ASEAN analytical validation guideline, RDC 166/2017, Taiwan analytical validation manual. See all standards.